SCHEMBL21453879

SCHEMBL21453879

c1cc(-c2cccc(-n3c4ccccc4c4ccccc43)c2)cc(-c2cncc(-n3c4ccccc4c4ccccc43)c2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.47
KDM4E B2RXH2 1/20 0.47
ATM Q13315 1/20 0.47
CHRNB4 P30926 1/20 0.38
CHRNA3 P32297 1/20 0.38
MAPT P10636 3/20 0.36
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
GABRA3 P34903 1/20 0.35
KMT2A Q03164 3/20 0.34
CYP11B2 P19099 3/20 0.34
CYP11B1 P15538 2/20 0.34
IL1R1 P14778 1/20 0.34
CYP1A2 P05177 1/20 0.34
METAP2 P50579 1/20 0.34
MEN1 O00255 2/20 0.33
MKNK1 Q9BUB5 1/20 0.33
MKNK2 Q9HBH9 1/20 0.33
LRRK2 Q5S007 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29511975 0.98 L3MBTL1 (0.48) L3MBTL1KDM4EATMCHRNB4CHRNA3
SCHEMBL10024691 0.98 L3MBTL1 (0.48) L3MBTL1KDM4EATMCHRNB4CHRNA3
SCHEMBL29358123 0.97 L3MBTL1 (0.50) L3MBTL1KDM4EATMCHRNB4CHRNA3
SCHEMBL612234 0.97 L3MBTL1 (0.50) L3MBTL1KDM4EATMCHRNB4CHRNA3
SCHEMBL11895266 0.97 KDM4E (0.46) L3MBTL1KDM4EATMCHRNB4CHRNA3
SCHEMBL18151976 0.97 L3MBTL1 (0.50) L3MBTL1KDM4EATMCHRNB4CHRNA3
SCHEMBL8400383 0.97 L3MBTL1 (0.50) L3MBTL1KDM4EATMCHRNB4CHRNA3
SCHEMBL29362914 0.97 L3MBTL1 (0.50) L3MBTL1KDM4EATMCHRNB4CHRNA3
SCHEMBL21028244 0.94 ATM (0.52) L3MBTL1KDM4EATMCHRNB4CHRNA3
SCHEMBL28436068 0.94 ATM (0.47) L3MBTL1KDM4EATMCHRNB4CHRNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11469381-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2022-10-11 US disclosed
US-20190312209-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-10-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11469381-B2 Condensed cyclic compound and organic light-emitting device including the same ARL1, CCNL2, CRY1 L3MBTL1 344/4885KDM4E 3923/4885ATM 723/4885
US-20190312209-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME ARL1, CCNL2, CRY1 L3MBTL1 344/4885KDM4E 3923/4885ATM 723/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.